Climara Transdermal System 0.025 mg/Day
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Climara Transdermal System 0.025 mg/Day, covering 2008-04-01 to 2008-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day [Phase 1]